Novel dna fragment elevating gene expression dose
CA 2347218 A1 · Owner: Japan Tobacco Inc. · Inventors: Takakura, Yoshimitsu; Ueki, Jun
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel DNA fragment elevating gene expression dose. This DNA fragment contains the base sequence of from the 1- to about 152-bases and the base sequence of from the 259- to about 374-bases in SEQ ID NO:1 and is capable of elevating gene expression dose.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 18, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 18, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.